ICML 2017 | Proton and photon therapy in managing hematological malignancies
Bouthaina Dabaja, MD from the MD Anderson Cancer Center, Houston, TX provides an overview of her work using proton therapy to reduce the late effects of lymphoma treatment. Dr Dabaja explains how proton therapy has been of instrumental value in reducing toxic radiation. This is important to lymphoma patients, as due to it being a highly curable disease, they will live long enough to see any lasting effects of radiation therapy. She explains some of the limitations of proton therapy and also how it compares to photons in managing hematological malignancies. Recorded at the International Conference on Malignant Lymphoma (ICML) 2017 held in Lugano, Switzerland.
Get great new content delivered to your inboxSign up